Anti-Obesity Drug Discovery and Development
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (3 years) | 5 |
| Citable Docs. (3 years) | 1 |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Anti-Obesity Drug Discovery and Development?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Anti-Obesity Drug Discovery and Development has an SJR of 0.133 and is ranked Q4.
What is the SJR and quartile of Anti-Obesity Drug Discovery and Development?
Anti-Obesity Drug Discovery and Development has an SJR (SCImago Journal Rank) of 0.133 and its best quartile is Q4.
What is the H-index of Anti-Obesity Drug Discovery and Development?
The H-index of Anti-Obesity Drug Discovery and Development is 1, meaning 1 of its articles have each been cited at least 1 times.
Is Anti-Obesity Drug Discovery and Development indexed in Scopus?
Anti-Obesity Drug Discovery and Development is listed as inactive in Scopus — Scopus is no longer adding new content for this title (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.